The DOI matches its Crossref record.
Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM
Abstract
Fasting and postprandial plasma glucose, free fatty acid (FFA), lactate, and insulin concentrations were measured at hourly intervals for 24 h in 27 nonobese individuals—9 with normal glucose tolerance, 9 with mild non-insulin-dependent diabetes mellitus (NIDDM, fasting plasma glucose < 175 mg/dl), and 9 with severe NIDDM (fasting plasma glucose > 250 mg/dl). In addition, hepatic glucose production (HGP) was measured from midnight to 0800 in normal individuals and patients with severe NIDDM. Plasma glucose concentration was highest in patients with severe NIDDM, lowest in those with normal glucose tolerance, and intermediate in those with mild NIDDM (two-way ANOVA, P < .001). Variations in plasma FFA and lactate levels of the three groups were qualitatively similar, with lowest concentrations seen in normal individuals, intermediate levels in the group with mild NIDDM, and the highest concentration in those with severe NIDDM (two-way ANOVA, P < .001). Of particular interest was the observation that plasma FFA concentrations were dramatically elevated from midnight to 0800 in patients with severe NIDDM. The 24-h insulin response was significantly increased in patients with mild NIDDM, with comparable values seen in the other two groups. Values for HGP fell progressively throughout the night in normal individuals and patients with severe NIDDM, despite a concomitant decline in plasma glucose and insulin levels. Although the magnitude of the fall in HGP was greater in NIDDM, the absolute value was significantly (P < .001) greater than normal throughout the period of observation. These results demonstrate that there are differences in substrate level between individuals with normal glucose tolerance and patients with NIDDM and differing degrees of glucose intolerance, unrelated to ambient insulin level, and these changes persist over 24 h.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The metabolic derangements of Type 2 diabetes include an increase in plasma NEFA concentrations [145], which has been shown to produce deleterious effects on the insulin-sensitive tissues and the beta cell.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [145]
In the citing paper
“Nondiabetic obese and type 2 diabetic individuals are characterized by day-long elevation in the plasma FFA concentration, which fails to suppress normally after ingestion of a mixed meal or an oral glucose load [60].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [60]
In the citing paper
“these results suggest that increased hepatic de novo lipogenesis precede the development of adipose tissue insulin resistance, which subsequently leads to increased flux of fatty acids to the liver (16, 17).”
From The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome (2007) · cites this paper as [17]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Items 101–200 of 749
Bruce, C. R., & Dyck, D. J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00150.2004 · Cited by 178
Ceddia, R. B. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803025 · Cited by 184
The importance of free fatty acids in the development of Type 2 diabetes
Wilding, J. P. H. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02186.x · Cited by 178
Cellular mechanisms of insulin resistance in humans
Shulman, G. I. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00350-1 · Cited by 177
The Emerging Functions of UCP2 in Health, Disease, and Therapeutics
Mattiasson, G., & Sullivan, P. G. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1 · Cited by 181
Bruce, C. R., Kriketos, A. D., Cooney, G. J., & Hawley, J. A. (2004) · Diabetologia · doi:10.1007/s00125-003-1265-7 · Cited by 176
Boden, G. H., Chen, X., Capulong, E., & Mozzoli, M. A. (2001) · Diabetes · doi:10.2337/diabetes.50.4.810 · Cited by 171
Muscle Lipid Metabolism: Role of Lipid Droplets and Perilipins
Morales, P. E., Bucarey, J. L., & Espinosa, A. (2017) · Journal of Diabetes Research · doi:10.1155/2017/1789395 · Cited by 179
Apelin Decreases Lipolysis via Gq, Gi, and AMPK-Dependent Mechanisms
Yue, P., Jin, H. H., Xu, S., Aillaud, M., Deng, A. C., Azuma, J., Kundu, R. K., Reaven, G. M., Quertermous, T., & Tsao, P. S. (2010) · Endocrinology · doi:10.1210/en.2010-0576 · Cited by 171
Self-citationInsulin action in adipocytes, adipose remodeling, and systemic effects
Santoro, A. N., McGraw, T. E., & Kahn, B. B. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.019 · Cited by 180
Insulin resistance and the sympathetic nervous system
Egan, B. M. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0028-7 · Cited by 172
PATHOGENESIS OF TYPE 2 DIABETES
Boden, G. H. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70216-4 · Cited by 173
Free fatty acids impair hepatic insulin extraction in vivo.
Wiesenthal, S. R., Sandhu, H., McCall, R. H., Tchipashvili, V., Yoshii, H., Polonsky, K. S., Shi, Z. Q., Lewis, G. F., Mari, A., & Giacca, A. (1999) · Diabetes · doi:10.2337/diabetes.48.4.766 · Cited by 167
State of the union between metabolism and the immune system in type 2 diabetes
Nikolajczyk, B. S., Jagannathan‐Bogdan, M., Shin, H., & Gyurko, R. (2011) · Genes and Immunity · doi:10.1038/gene.2011.14 · Cited by 168
Adipocyte triglyceride lipase expression in human obesity
Steinberg, G. R., Kemp, B. E., & Watt, M. J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00235.2007 · Cited by 166
Regulation and function of triacylglycerol lipases in cellular metabolism
Watt, M. J., & Steinberg, G. R. (2008) · Biochemical Journal · doi:10.1042/bj20080305 · Cited by 165
Novel insights into the pathogenesis of uric acid nephrolithiasis
Maalouf, N. M., Cameron, M. A., Moe, O. W., & Sakhaee, K. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200403000-00006 · Cited by 165
Tubular atrophy in the pathogenesis of chronic kidney disease progression
Schelling, J. R. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3169-4 · Cited by 175
Lipid Composition of Cell Membranes and Its Relevance in Type 2 Diabetes Mellitus
Weijers, R. N. M. (2012) · Current Diabetes Reviews · doi:10.2174/157339912802083531 · Cited by 165
Role of Oxidative Stress in Diabetic Cardiomyopathy
Geest, B. D., & Mishra, M. (2022) · Antioxidants · doi:10.3390/antiox11040784 · Cited by 172
Jenssen, T. G., Nurjhan, N., Consoli, A., & Gerich, J. E. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114735 · Cited by 162
Muscular diacylglycerol metabolism and insulin resistance
Timmers, S., Schrauwen, P., & den Bosch, J. D. V. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.12.002 · Cited by 163
Bradley, R. L., Fisher, F. M., & Maratos–Flier, E. (2008) · Obesity · doi:10.1038/oby.2008.39 · Cited by 163
Artwohl, M., Roden, M., Waldhäusl, W. K., Freudenthaler, A., & Baumgartner-Parzer, S. M. (2003) · The FASEB Journal · doi:10.1096/fj.03-0301fje · Cited by 162
The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM
Markovic, T. P., Jenkins, A. B., Campbell, L. V., Furler, S. M., Kraegen, E. W., & Chisholm, D. J. (1998) · Diabetes Care · doi:10.2337/diacare.21.5.687 · Cited by 154
Dietary hyperglycemia, glycemic index and metabolic retinal diseases
Chiu, C., & Taylor, A. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.09.001 · Cited by 166
Altered postprandial hormone and metabolic responses in a simulated shift work environment
Ribeiro, D., Hampton, S., Morgan, L., Deacon, S., & Arendt, J. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1580305 · Cited by 155
Kowalski, G. M., & Bruce, C. R. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00165.2014 · Cited by 154
Free Fatty Acids—The Link Between Obesity and Insulin Resistance
Boden, G. H. (2001) · Endocrine Practice · doi:10.4158/ep.7.1.44 · Cited by 155
Metabolic interactions between glucose and fatty acids in humans
Wolfe, R. R. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.3.519s · Cited by 149
Aitman, T. J., Gotoda, T., Evans, A. L., Imrie, H., Heath, K. E., Trembling, P. M., Truman, H., Wallace, C., Rahman, A., Doré, C. J., et al. (1997) · Nature Genetics · doi:10.1038/ng0697-197 · Cited by 151
Astaxanthin ameliorates features of metabolic syndrome in SHR/NDmcr-cp
Hussein, G. M. E., Nakagawa, T., Goto, H., Shimada, Y., Matsumoto, K., Sankawa, U., & Watanabe, H. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.09.041 · Cited by 150
Free fatty acids FFA a link between obesity and insulin resistance
Boden, G. H. (1998) · Frontiers in bioscience · doi:10.2741/a272 · Cited by 148
Pathophysiology of prediabetes
Abdul-Ghani, M. A., & DeFronzo, R. A. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0032-7 · Cited by 149
Lee, K.-U., Lee, I. K., Han, J., Song, D., Kim, Y., Song, H. S., Kim, H. S., Lee, W. J., Koh, E. H., Song, K., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000170075.73039.5b · Cited by 149
Sriwijitkamol, A., Christ-Roberts, C. Y., Berria, R., Eagan, P. A., Pratipanawatr, T., DeFronzo, R. A., Mandarino, L. J., & Musi, N. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0677 · Cited by 146
Hoeck, V. V., Leroy, J., Arias‐Álvarez, M., Rizos, D. V., Gutiérrez‐Adán, A., Schnorbusch, K., Bols, P. E. J., Leese, H. J., & Sturmey, R. G. (2012) · Reproduction · doi:10.1530/rep-12-0174 · Cited by 154
Diabetes: Have We Got It All Wrong?
Pories, W. J., & Dohm, G. L. (2012) · Diabetes Care · doi:10.2337/dc12-0684 · Cited by 149
van de Weijer, T., Phielix, E., Bilet, L., Williams, E. G., Ropelle, E. R., Bierwagen, A., Livingstone, R., Nowotny, P., Sparks, L. M., Paglialunga, S., et al. (2015) · Diabetes · doi:10.2337/db14-0667 · Cited by 139
Cincotta, A. H., MEIER, A. H., & Cincotta, M. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.10.1683 · Cited by 138
Metformin‐associated lactic acidosis ( MALA ): M oving towards a new paradigm
Lalau, J., Kajbaf, F., Protti, A., Christensen, M. M. H., Broe, M. E. D., & Wiernsperger, N. F. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12974 · Cited by 143
Pharmacological Antilipolysis Restores Insulin Sensitivity During Growth Hormone Exposure
Nielsen, S., Møller, N., Christiansen, J. S., & Jørgensen, J. O. L. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2301 · Cited by 136
High–saturated-fat diet induces gestational diabetes and placental vasculopathy in C57BL/6 mice
Liang, C., Decourcy, K. R., & Prater, M. R. (2009) · Metabolism · doi:10.1016/j.metabol.2009.10.015 · Cited by 136
Contributions of Fasting and Postprandial Glucose to Hemoglobin A1c
Monnier, L., & Colette, C. (2006) · Endocrine Practice · doi:10.4158/ep.12.s1.42 · Cited by 135
Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance
Han, M. S., Lim, Y.-M., Quan, W., Kim, J. R., Chung, K. W., Kang, M., Kim, S., Park, S. Y., Han, J., Park, S., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m014787 · Cited by 136
Boden, G., Chen, X., & Iqbal, N. (1998) · Diabetes · doi:10.2337/diabetes.47.10.1609 · Cited by 134
Page, L. M. L., Rider, O. J., Lewis, A. J., Ball, V., Clarke, K., Johansson, E., Carr, C. A., Heather, L. C., & Tyler, D. J. (2015) · Diabetes · doi:10.2337/db14-1560 · Cited by 132
Metabolism, hypoxia and the diabetic heart
Heather, L. C., & Clarke, K. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.01.007 · Cited by 132
Metabolic and molecular basis of insulin resistance
Bajaj, M., & DeFronzo, R. A. (2003) · Journal of Nuclear Cardiology · doi:10.1016/s1071-3581(03)00520-8 · Cited by 131
Lü, Z., Mu, Y., Wang, B., Li, X.-L., Lu, J., Li, J.-Y., Pan, C., Yanase, T., & Nawata, H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00449-2 · Cited by 132
Liu, X., Xue, Y., Liu, C., Lou, Q., Wang, J., Yanagita, T., Xue, C., & Wang, Y. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-109 · Cited by 128
Molecular mechanisms of lipid‐induced insulin resistance in muscle, liver and vasculature
Krebs, M., & Roden, M. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00439.x · Cited by 130
Role of NFAT5 in Inflammatory Disorders Associated with Osmotic Stress
Neuhofer, W. (2010) · Current Genomics · doi:10.2174/138920210793360961 · Cited by 136
Induction of Hepatic Glucose-6-Phosphatase Gene Expression by Lipid Infusion
Massillon, D., Barzilai, N., Hawkins, M. A., Prus-Wertheimer, D., & Rossetti, L. (1997) · Diabetes · doi:10.2337/diab.46.1.153 · Cited by 125
Systemic and regional free fatty acid metabolism in type 2 diabetes
Basu, A., Basu, R., Shah, P., Vella, A., Rizza, R. A., & Jensen, M. D. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.6.e1000 · Cited by 123
Uehara, Y., Miura, S.-I., von Eckardstein, A., Abe, S., Fujii, A., Matsuo, Y., Rust, S., Stefan Lorkowski, A., Assmann, G., Yamada, T., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.04.018 · Cited by 122
Metabolic effects of low glycaemic index diets
Radulian, G., Rusu, E., Dragomir, A., & Posea, M. (2009) · Nutrition Journal · doi:10.1186/1475-2891-8-5 · Cited by 119
Harvey, K. A., Walker, C. L., Xu, Z., Whitley, P., Pavlina, T. M., Hise, M. E., Zaloga, G. P., & Siddiqui, R. A. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m010371 · Cited by 123
Carlsson, M., Wessman, Y., Almgren, P., & Groop, L. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1588 · Cited by 95
Guo, L., & Tabrizchi, R. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.009 · Cited by 117
Green, C. D., & Olson, L. K. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00544.2010 · Cited by 117
The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes
Tang, C., & Oram, J. F. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.03.011 · Cited by 115
Dietary Flavonoids in the Prevention of T2D: An Overview
Alkhalidy, H., Wang, Y., & Liu, D. (2018) · Nutrients · doi:10.3390/nu10040438 · Cited by 123
An Unsuspected Metabolic Role for Atrial Natriuretic Peptides
Lafontan, M., Moro, C., Sengenès, C., Galitzky, J., Crampes, F., & Berlan, M. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000183728.14712.d8 · Cited by 114
Effect of renal lipid accumulation on proximal tubule Na+/H+exchange and ammonium secretion
Bobulescu, I. A., Dubree, M., Zhang, J., McLeroy, P., & Moe, O. W. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00550.2007 · Cited by 113
Effects of Free Fatty Acids Per Se on Glucose Production, Gluconeogenesis, and Glycogenolysis
Stæhr, P., Nielsen, O. H., Landau, B. R., Chandramouli, V., Holst, J. J., & Beck‐Nielsen, H. (2003) · Diabetes · doi:10.2337/diabetes.52.2.260 · Cited by 114
Rheb-regulated mitochondrial pyruvate metabolism of Schwann cells linked to axon stability
Jia, L., Liao, M., Mou, A., Zheng, Q., Yang, W., Yu, Z., Cui, Y., Xia, X., Qin, Y. N., Chen, M., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.09.013 · Cited by 112
Stacpoole, P. W. (1993) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30163-4 · Cited by 111
Juel, C., Holten, M., & Dela, F. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2003.058222 · Cited by 110
Disordered metabolism in diabetes: Have we underemphasized the fat component?
McGarry, J. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240550005 · Cited by 107
Perseghin, G., Scifo, P., Pagliato, E., Battezzati, A., Benedini, S., Soldini, L., Testolin, G., Del Maschio, A., & Luzi, L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7666 · Cited by 112
Rico, J. E., Bandaru, V. V. R., Dorskind, J. M., Haughey, N. J., & McFadden, J. W. (2015) · Journal of Dairy Science · doi:10.3168/jds.2015-9519 · Cited by 107
Elevated Plasma Levels of Chemerin in Newly Diagnosed Type 2 Diabetes Mellitus with Hypertension
Yang, M., Yang, G., Dong, J., Liu, Y., Zong, H., Liu, H., Boden, G. H., & Li, L. (2010) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181ec5db2 · Cited by 103
Type 2 diabetes mellitus: not quite exciting enough?
Ashcroft, F. M. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh066 · Cited by 102
Kir6.2 Polymorphisms Sensitize β-Cell ATP-Sensitive Potassium Channels to Activation by Acyl CoAs
Riedel, M. J., Boora, P., Steckley, D., de Vries, G., & Light, P. E. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2630 · Cited by 99
Sakamoto, J., Barr, R. L., Kavanagh, K. M., & Lopaschuk, G. D. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.4.h1196 · Cited by 100
Insulin resistance and cardiovascular disease
Egan, B. M. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02078-7 · Cited by 98
Morning Hyperglycemic Excursions
Monnier, L., Colette, C., Rabasa-Lhoret, R., Lapinski, H., Caubel, C., Avignon, A., & Boniface, H. (2002) · Diabetes Care · doi:10.2337/diacare.25.4.737 · Cited by 96
Khan, I. M., Perrard, X. D., Perrard, J. L., Mansoori, A., Smith, C. W., Wu, H., & Ballantyne, C. M. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.01.011 · Cited by 103
Protection From Obesity and Insulin Resistance in Mice Overexpressing Human Apolipoprotein C1
Jong, M. C., Voshol, P. J., Muurling, M., Dahlmans, V. E. H., Romijn, J. A., Pijl, H., & Havekes, L. M. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2779 · Cited by 98
Radziuk, J., & Pye, S. (2006) · Diabetologia · doi:10.1007/s00125-006-0273-9 · Cited by 95
Stojiljković, M. P., Lopes, H. F., Zhang, D., Morrow, J. D., Goodfriend, T. L., & Egan, B. M. (2002) · Journal of Hypertension · doi:10.1097/00004872-200206000-00036 · Cited by 94
Wang, Y., Simar, D., & Singh, M. A. F. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.928 · Cited by 94
Free fatty acids sensitize dendritic cells to amplify TH1/TH17‐immune responses
Stelzner, K., Herbert, D., Popkova, Y., Lorz, A., Schiller, J., Gericke, M. T., Klöting, N., Blüher, M., Franz, S., Simon, J. C., et al. (2016) · European Journal of Immunology · doi:10.1002/eji.201546263 · Cited by 95
A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1
Yabuki, C., Komatsu, H., Tsujihata, Y., Risa, M., Ito, R., Kae, M.-N., Sakuma, K., Miyawaki, K., Kikuchi, N., Takeuchi, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076280 · Cited by 94
Fatty Acid-Induced Insulin Resistance in Adipocytes
Fung, M. K. Y., Williford, J., Wells, A. H., & Hardy, R. W. (1997) · Endocrinology · doi:10.1210/endo.138.10.5458 · Cited by 94
Hawkins, M. A., Tonelli, J., Kishore, P., Stein, D. T., Ragucci, E., Gitig, A., & Reddy, K. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2748 · Cited by 91
Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes.
Boden, G., & Chen, X. (1999) · Diabetes · doi:10.2337/diabetes.48.3.577 · Cited by 91
Bimagrumab improves body composition and insulin sensitivity in insulin‐resistant individuals
Garito, T., Roubenoff, R., Hompesch, M., Morrow, L., Gomez, K., Rooks, D., Meyers, C., Buchsbaum, M. S., Neelakantham, S., Swan, T., et al. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13042 · Cited by 88
Free Fatty Acids and Their Metabolism Affect Function and Survival of Podocytes
Sieber, J., & Jehle, A. W. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00186 · Cited by 90
van Loon, L. J. C., Thomason-Hughes, M., Constantin‐Teodosiu, D., Koopman, R., Greenhaff, P. L., Hardie, D. G., KEIZER, H. A., Saris, W. H. M., & Wagenmakers, A. J. M. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00092.2005 · Cited by 86
Sandberg, J. C., Björck, I., & Nilsson, A. C. (2017) · Nutrition Journal · doi:10.1186/s12937-017-0246-5 · Cited by 87
Sheng, Y., Zheng, S., Ma, T., Zhang, C., Ou, X., He, X., Xu, W., & Huang, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-12245-2 · Cited by 87
Oleic Acid–Induced Mitogenic Signaling in Vascular Smooth Muscle Cells
Lü, G., Morinelli, T. A., Meier, K. E., Rosenzweig, S. A., & Egan, B. M. (1996) · Circulation Research · doi:10.1161/01.res.79.3.611 · Cited by 86
The Contribution of Lipotoxicity to Diabetic Kidney Disease
Schelling, J. R. (2022) · Cells · doi:10.3390/cells11203236 · Cited by 93
Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys
Tang, C., Kanter, J. E., Bornfeldt, K., LeBoeuf, R. C., & Oram, J. F. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m003525 · Cited by 85
Mehmeti, I., Lortz, S., Avezov, E., Jörns, A., & Lenzen, S. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.07.021 · Cited by 83
Apelin and insulin resistance: Another arrow for the quiver?
Xu, S., Tsao, P. S., & Yue, P. (2011) · Journal of Diabetes · doi:10.1111/j.1753-0407.2011.00132.x · Cited by 83
Axelrod, C. L., Fealy, C. E., Erickson, M. L., Davuluri, G., Fujioka, H., Dantas, W. S., Huang, E., Belmont, K. P., Mey, J. T., King, W. T., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154803 · Cited by 82
Type 2 diabetes in South Asians: A pathophysiologic focus on the Asian-Indian epidemic
Bajaj, M., & Banerji, M. A. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0026-4 · Cited by 84
Metadata
- Authors
- Reaven, G. M., Hollenbeck, C., Jeng, C.-Y., Wu, M. S., & Chen, Y.-D. I.
- Affiliations
- VA Palo Alto Health Care System (US)
- ORCID
- Chen, Yii-Der Ida
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1988-08-01
- Volume
- 37
- Issue
- 8
- Pages
- 1020-1024
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2109820048
- Cited by
- 753
- References
- 0
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 13 · 2023: 13 · 2022: 6 · 2021: 21 · 2020: 27 · 2019: 22 · 2018: 25 · 2017: 32 · 2016: 27 · 2015: 28 · 2014: 37 · 2013: 34 · 2012: 27
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK30732)
- National Center for Research Resources (RR-00070-26)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 2 diabetes, plasma glucose, free fatty acids, lactate, insulin response, hepatic glucose production, circadian variation, fasting blood glucose, postprandial blood glucose, glucose tolerance
- MeSH terms
- Blood Glucose, Circadian Rhythm, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Humans, Insulin, Lactates, Monitoring, Physiologic, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review